To arm the im­mune sys­tem for sus­tained at­tack against HIV, NIH sci­en­tists take to vi­ral vec­tors

While stem cell treat­ment for HIV — en­gi­neered to stop the virus from repli­cat­ing with­in the body by re­plac­ing the pa­tient’s own im­mune cells with donor cells that can re­sist HIV in­fec­tion — is be­gin­ning to look like a cure, NIH re­searchers are gain­ing mo­men­tum in us­ing a vi­ral vec­tor to trans­plant an an­ti­body gene in­to hu­man cells to elic­it an im­mune re­sponse to the virus over an ex­tend­ed pe­ri­od.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER